Doctor of Osteopathy Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

Ann Habenicht

Neuromusculoskeletal Medicine & OMM Beavercreek, OH Doctor of Osteopathy

NPI 1497701890 CMS profile 889305

2510 Commons Blvd, Ste 240A, Beavercreek, OH 45431

Open in the dashboard

General payments

$560

44 records reported · program years 2019–2024

Research payments

$0

Paid to them · None reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Ann Habenicht of Beavercreek, OH is reported in the CMS Open Payments database as having received $560 across 44 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 75th percentile of Neuromusculoskeletal Medicine & OMM profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $94 6
2023 General $235 21
2022 General $14 1
2019 General $218 16

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ann Habenicht
  • Neuromusculoskeletal Medicine & OMM median
  • Middle half of Neuromusculoskeletal Medicine & OMM
  • National median

In program year 2025, general payments to Ann Habenicht were reported at $0. Among 217 Neuromusculoskeletal Medicine & OMM profiles paid that year, the median was $119 and the middle half received between $36 and $380.

Show as a table
Year Ann Habenicht Neuromusculoskeletal Medicine & OMM median Middle half National median
2019 $218 $92 $27–$283 $163
2020 $0 $85 $20–$411 $114
2021 $0 $120 $32–$548 $132
2022 $14 $96 $32–$518 $149
2023 $235 $92 $33–$328 $160
2024 $94 $122 $35–$378 $164
2025 $0 $119 $36–$380 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. Collegium Pharmaceutical, Inc. $383 31 payments
  2. Biodelivery Sciences International, Inc. $113 9 payments
  3. Vertiflex, Inc. $28 1 payment
  4. Pfizer Inc. $26 2 payments
  5. Takeda Pharmaceuticals U.S.A., Inc. $10 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Food and Beverage $560 44 payments
Products named General payments · program years 2019–2024
  1. BELBUCA $312 25 payments
  2. BUNAVAIL 2.1 mg 30-count box $97 8 payments
  3. BUNAVAIL 2.1 mg single pouch $97 8 payments
  4. BUNAVAIL 4.2 mg 30-count box $97 8 payments
  5. BUNAVAIL 4.2 mg single pouch $97 8 payments
  6. BUNAVAIL 6.3 mg 30-count box $97 8 payments
  7. XTAMPZA $71 6 payments
  8. Superion ISS $28 1 payment
  9. LYRICA $26 2 payments
  10. Trintellix $10 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 15 drugs

Part D claims

657

Median for Osteopathic Manipulative Medicine: 311

Drug cost

$35,548

Median for Osteopathic Manipulative Medicine: $11,323

Branded share of claims

43.2%

Median for Osteopathic Manipulative Medicine: 19.9%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Belbuca Buprenorphine Hcl Brand 21 $18,630
Buprenorphine Generic 12 $5,757
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 156 $4,021
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 107 $2,724
Oxycodone Hcl Generic 67 $1,807
Gabapentin Generic 73 $923
Pregabalin Generic 45 $871
Tizanidine Hcl Generic 37 $226
Tramadol Hcl Generic 28 $144
Cyclobenzaprine Hcl Generic 24 $139

The 10 drugs with the highest cost, of 15 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 526 Part D prescribers listed as Osteopathic Manipulative Medicine; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 13 billing codes

Paid by Medicare

$42,422

Medicare's payments for the services billed

Medicare patients

92

Average age 72

Services billed

795

62 women, 30 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 67%
High blood pressure 63%
Depression 29%
Diabetes 27%
Ischemic heart disease 27%
Osteoporosis 22%
COPD 18%
Atrial fibrillation 17%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
BELBUCA
  • Collegium Pharmaceutical, Inc. $94
$94 21 —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

44 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neuromusculoskeletal Medicine & OMM in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record